Savall Brad M, Meduna Steven P, Venable Jennifer, Wei Jianmei, Smith Russell C, Hack Michael D, Thurmond Robin L, McGovern Patricia, Edwards James P
Janssen Pharmaceutical Research & Development, LLC, 3210 Merryfield Row, San Diego, CA 92121, United States.
Bioorg Med Chem Lett. 2014 Dec 1;24(23):5489-92. doi: 10.1016/j.bmcl.2014.10.013. Epub 2014 Oct 13.
During the course of our efforts toward the discovery of human histamine H4 antagonists from a series of 2-aminiopyrimidines, it was noted that a 6-trifluoromethyl group dramatically reduced affinity of the series toward the histamine H4 receptor. This observation was further investigated by synthesizing a series of ligands that varied in pKa of the pyrimidine derived H4 ligands by over five orders of magnitude and the effect on histamine H4 affinity. This trend was then extended to the discovery of C-linked piperidinyl-2-amino pyridines as histamine H4 receptor antagonists.
在我们从一系列2-氨基嘧啶中发现人组胺H4拮抗剂的过程中,注意到6-三氟甲基基团显著降低了该系列对组胺H4受体的亲和力。通过合成一系列嘧啶衍生的H4配体的pKa相差超过五个数量级的配体,并研究其对组胺H4亲和力的影响,对这一观察结果进行了进一步研究。然后,这一趋势扩展到发现C-连接的哌啶基-2-氨基吡啶作为组胺H4受体拮抗剂。